RHUMBLINE ADVISERS - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$2,251,000
+81.5%
81,740
+8.7%
0.00%
+50.0%
Q1 2021$1,240,000
-16.4%
75,227
-6.6%
0.00%0.0%
Q4 2020$1,484,000
+55.2%
80,542
+14.7%
0.00%
+100.0%
Q3 2020$956,000
-22.4%
70,231
+2.1%
0.00%
-50.0%
Q2 2020$1,232,000
+199.0%
68,753
+66.5%
0.00%
+100.0%
Q1 2020$412,000
+31.2%
41,283
+7.2%
0.00%0.0%
Q4 2019$314,000
-14.7%
38,522
+3.8%
0.00%0.0%
Q3 2019$368,000
-22.0%
37,109
-0.6%
0.00%0.0%
Q2 2019$472,000
+46.1%
37,349
+17.8%
0.00%0.0%
Q1 2019$323,000
+319.5%
31,712
+207.4%
0.00%
Q4 2018$77,00010,3150.00%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders